Immune system and melanoma biology: a balance between immunosurveillance and immune escape
Metrics: PDF 1761 views | HTML 2623 views | ?
Anna Passarelli1, Francesco Mannavola1, Luigia Stefania Stucci1, Marco Tucci1 and Francesco Silvestris1
1Department of Biomedical Sciences and Human Oncology, University of Bari ‘Aldo Moro’, Bari, Italy
Anna Passarelli, email: email@example.com
Keywords: melanoma; immune system; immunogenicity; immunoediting; immune escape
Received: May 26, 2017 Accepted: September 21, 2017 Published: October 31, 2017
Melanoma is one of the most immunogenic tumors and its relationship with host immune system is currently under investigation. Many immunomodulatory mechanisms, favoring melanomagenesis and progression, have been described to interfere with the disablement of melanoma recognition and attack by immune cells resulting in immune resistance and immunosuppression. This knowledge produced therapeutic advantages, such as immunotherapy, aiming to overcome the immune evasion.
Here, we review the current advances in cancer immunoediting and focus on melanoma immunology, which involves a dynamic interplay between melanoma and immune system, as well as on effects of “targeted therapies” on tumor microenvironment for combination strategies.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.